FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

222993009: [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use (disorder)


    Status: retired, Primitive. Date: 31-Jan 2009. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2567666016 [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use (disorder) en Fully specified name Active Initial character case insensitive SNOMED CT core
    335686011 [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use en Synonym Active Initial character case insensitive SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Is a Haematological agents adverse reaction false Inferred relationship Some
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Causative agent Hematologic agent false Inferred relationship Some
    [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Is a [X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    [X]Clopidogrel causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Iron preparations and other anti-hypochromic-anaemia preparations causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Anticoagulants causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Anticoagulant antagonists, vitamin K and other coagulants causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Antithrombotic drugs [platelet-aggregation inhibitors] causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Thrombolytic drugs causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Natural blood and blood products causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Other and unspecified agents affecting blood constituents causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some
    [X]Plasma substitutes causing adverse effects in therapeutic use Is a False [X]Agents primarily affecting blood constituents causing adverse effects in therapeutic use Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    MOVED TO association reference set

    Back to Start